Fountoulakis M - Search Results

1

Manifold decrease of sialic acid synthase in fetal Down syndrome brain.

Gulesserian T, Engidawork E, Fountoulakis M, Lubec G. Gulesserian T, et al. Among authors: fountoulakis m. Amino Acids. 2007 Jan;32(1):141-4. doi: 10.1007/s00726-006-0325-y. Epub 2006 May 26. Amino Acids. 2007. PMID: 16729195 Clinical Trial.

2

Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).

Peyrl A, Weitzdoerfer R, Gulesserian T, Fountoulakis M, Lubec G. Peyrl A, et al. Among authors: fountoulakis m. Electrophoresis. 2002 Jan;23(1):152-7. doi: 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T. Electrophoresis. 2002. PMID: 11824616

3

Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.

Gulesserian T, Kim SH, Fountoulakis M, Lubec G. Gulesserian T, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 Feb 15;291(1):62-7. doi: 10.1006/bbrc.2002.6389. Biochem Biophys Res Commun. 2002. PMID: 11829462

4

Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex.

Bajo M, Fruehauf J, Kim SH, Fountoulakis M, Lubec G. Bajo M, et al. Among authors: fountoulakis m. Proteomics. 2002 Nov;2(11):1539-46. doi: 10.1002/1615-9861(200211)2:11<1539::AID-PROT1539>3.0.CO;2-C. Proteomics. 2002. PMID: 12442254

5

Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.

Bernert G, Fountoulakis M, Lubec G. Bernert G, et al. Among authors: fountoulakis m. Proteomics. 2002 Dec;2(12):1752-7. doi: 10.1002/1615-9861(200212)2:12<1752::AID-PROT1752>3.0.CO;2-Y. Proteomics. 2002. PMID: 12469345

6

Expression of hypothetical proteins in human fetal brain: increased expression of hypothetical protein 28.5kDa in Down syndrome, a clue for its tentative role.

Engidawork E, Gulesserian T, Fountoulakis M, Lubec G. Engidawork E, et al. Among authors: fountoulakis m. Mol Genet Metab. 2003 Apr;78(4):295-301. doi: 10.1016/s1096-7192(03)00046-5. Mol Genet Metab. 2003. PMID: 12706381

7

Derangement of hypothetical proteins in fetal Down's syndrome brain.

Shin JH, Gulesserian T, Weitzdoerfer R, Fountoulakis M, Lubec G. Shin JH, et al. Among authors: fountoulakis m. Neurochem Res. 2004 Jun;29(6):1307-16. doi: 10.1023/b:nere.0000023617.49590.19. Neurochem Res. 2004. PMID: 15176487

8

Differential expression of molecular chaperones in brain of patients with Down syndrome.

Yoo BC, Vlkolinsky R, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Yoo BC, et al. Among authors: fountoulakis m. Electrophoresis. 2001 Apr;22(6):1233-41. doi: 10.1002/1522-2683()22:6<1233::AID-ELPS1233>3.0.CO;2-M. Electrophoresis. 2001. PMID: 11358150

9

Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome.

Engidawork E, Juranville JF, Fountoulakis M, Dierssen M, Lubec G. Engidawork E, et al. Among authors: fountoulakis m. J Neural Transm Suppl. 2001;(61):117-30. doi: 10.1007/978-3-7091-6262-0_10. J Neural Transm Suppl. 2001. PMID: 11771738

10

Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.

Engidawork E, Balic N, Juranville JF, Fountoulakis M, Dierssen M, Lubec G. Engidawork E, et al. Among authors: fountoulakis m. J Neural Transm Suppl. 2001;(61):149-62. doi: 10.1007/978-3-7091-6262-0_12. J Neural Transm Suppl. 2001. PMID: 11771740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters